This analysis reveals enhanced mutagenesis and stable gene expression in Anopheles sinensis, suggesting significant utility for transgenic approaches.
The CRISPR/Cas9 system deployed through crosses of transgenic lines expressing Cas9 and gRNA facilitates efficient mutagenesis. However, its application in non-model insects remains limited, primarily due to a lack of well-characterized promoters capable of driving robust and stable expression of Cas9 and gRNA. In the malaria mosquito Anopheles sinensis, we evaluated several ovary-biased promoters-Asvasa2, Aszpg, and Asnanos-for driving Cas9 expression. Notably, the Asvasa2 promoter mediated mutagenesis in nearly 60% of G0 individuals following microinjection of gRNAAswhite. Among four RNA polymerase III promoters derived from AsU6 genes, AsU6-1 yielded the highest gRNA transcriptional output, enabling 62% editing efficiency in G0 offspring. In addition, hybrid crosses between established transgenic lines demonstrated that the Asvasa2-Cas9 and AsU6-1-gRNA combination enabled complete germline editing penetrance, where all F2 progeny inherited the intended mutations. This work provides an essential genetic toolkit for synthetic biology applications in Anopheles mosquitoes and a scalable framework for engineering other non-model insects.
No takes yet. Share an insight, caveat, or question.
Hong et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: